Anders Blanck is Director-General for Lif – the association for the research-based pharmaceutical companies in Sweden, representing 90 companies involved in pharmaceutical R&D and innovation.
He is chair of the Board of the Swedish e-Verification organization (e-VIS), and member of the Swedish Government’s Life Science Advisory Board and several other Boards and think-tanks within the Swedish Life Science-sector.
At European level he is a Board member of EFPIA (European Federation for the research based pharmaceutical industry) and vice chair of EFPIA’s Heads of National Association’s Council. At global level he is member of IFPMA’s (International Federation of Pharmaceutical Manufacturers and Associations) Council as well as Heads of National Associations Committee.
Previously, he has been the Director-General for Health and Head of the Healthcare Division at the Swedish Ministry of Health and Social Affairs, and Board member of the Karolinska Institute and the Swedish Anti-Corruption Institute.